hematology and oncology
Prothrombin (Factor II) 20210 Gene Mutation
Treatment of Prothrombin (Factor II) 20210 Gene Mutation
Anticoagulation Direct oral anticoagulants (DOACs) orwarfarincan be used for prevention and treatment of venous thrombosis in patients with one (heterozygosity) or two (homozygosity) copies of the prothrombin 20210 gene mutation. 